Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct;146(4):381-383.
doi: 10.1111/acps.13483. Epub 2022 Aug 3.

Psychotropic medication use in pediatric population during COVID-19 pandemic

Ilari Kuitunen  1   2
Affiliations

Psychotropic medication use in pediatric population during COVID-19 pandemic

Ilari Kuitunen. Acta Psychiatr Scand. 2022 Oct.
No abstract available

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Psychotropic medication user prevalence per 1000 children aged 6–12 years in Finland from 2019 to 2022. Yearly quarters of the first pandemic year (April 2020 to March 2021) and the second pandemic year (April 2021 to March 2022) compared with pre‐pandemic year April 2019 to March 2020.
See this image and copyright information in PMC

References

    1. Racine N, McArthur BA, Cooke JE, Eirich R, Zhu J, Madigan S. Global prevalence of depressive and anxiety symptoms in children and adolescents during COVID‐19: a meta‐analysis. JAMA Pediatr. 2021;175(11):1142‐1150. doi: 10.1001/jamapediatrics.2021.2482 - DOI - PMC - PubMed
    1. Viner R, Russell S, Saulle R, et al. School closures during social lockdown and mental health, health behaviors, and well‐being among children and adolescents during the first COVID‐19 wave: a systematic review. JAMA Pediatr. 2022;176(4):400‐409. doi: 10.1001/jamapediatrics.2021.5840 - DOI - PubMed
    1. Krass P, Dalton E, Doupnik SK, Esposito J. US pediatric emergency department visits for mental health conditions during the COVID‐19 pandemic. JAMA Netw Open. 2021;4(4):e218533. doi: 10.1001/jamanetworkopen.2021.8533 - DOI - PMC - PubMed
    1. Levaillant M, Wathelet M, Lamer A, Riquin E, Gohier B, Hamel‐Broza JF. Impact of COVID‐19 pandemic and lockdowns on the consumption of anxiolytics, hypnotics and antidepressants according to age groups: a French nationwide study. Psychol Med. 2021;1‐7. doi: 10.1017/S0033291721004839 - DOI - PMC - PubMed
    1. Raman SR, Man KKC, Bahmanyar S, et al. Trends in attention‐deficit hyperactivity disorder medication use: a retrospective observational study using population‐based databases. Lancet Psychiatry. 2018;5(10):824‐835. doi: 10.1016/S2215-0366(18)30293-1 - DOI - PubMed

Substances